GINGER MCMILLIAN: Open Payments
NPI 1306237664 · MONTGOMERY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 16 payments from 12 companies in 2025. Trend: 2023 $280 · 2024 $362 · 2025 $387
Food & beverage: $288Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $99 |
| PFIZER INC. | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $31 |
| Novo Nordisk Inc | 1 | $24 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Amgen Inc. | 1 | $17 |
| Cranial Technologies, Inc | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: PREVNAR 20, AIRSUPRA, NURTEC ODT, Ozempic, CONTRAVE, OTEZLA, Doc Band, FARXIGA.
Industry payments across TX — which companies pay providers there.
